EMS

EMS is the leading pharmaceutical company in Brazil, with a 45-year establishment record and 100% national capital. It operates from strategically located industrial plants in São Bernardo do Campo and Hortolândia, São Paulo. The company's success is attributed to its core values of daring, simplicity, excellence, and responsibility. This commitment to excellence has propelled EMS to the top of the industry, driven by continuous investments in structure and research, expansive product lines, and a pioneering attitude.

Having been the first Brazilian laboratory to export medicine products to Europe and to produce medicine products in fractioned packing and generics within the country, EMS is actively reinventing the pharmaceutical market.

EMS presents itself as a potential investment opportunity within the pharmaceutical industry, given its strong market presence and innovative approach. Given its established history and continued expansion, this could be an attractive prospect for venture capital investors seeking to tap into the burgeoning Brazilian pharmaceutical sector.